GridAI Technologies (GRDX) Income towards Parent Company (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Income towards Parent Company came in at $504510.0 in Q4 2025, up 214.78% YoY from $160275.1 in Q4 2024, and up 377.27% on a QoQ basis from -$181953.0 in Q3 2025.
GridAI Technologies (GRDX) Income towards Parent Company (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Income towards Parent Company data on file, last reported at $504510.0 in Q4 2025.
- Quarterly Income towards Parent Company rose 214.78% year-over-year to $504510.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$948888.0 (down 127.01% YoY) and the FY2025 annual result came in at -$312298.0, up 87.2% from the prior year.
- Income towards Parent Company climbed to $504510.0 in Q4 2025, from -$181953.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $5.8 million in Q1 2024 to a low of -$30.9 million in Q3 2021.
- A 5-year average of -$4.3 million and a median of -$2.9 million in 2022 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2021 — Income towards Parent Company sank 482.0% — and 2024, when it soared 241.51%.
- Tracing GRDX's Income towards Parent Company over 5 years: stood at -$11.2 million in 2021, then soared by 79.58% to -$2.3 million in 2022, then sank by 79.85% to -$4.1 million in 2023, then surged by 89.29% to -$439555.0 in 2024, then soared by 214.78% to $504510.0 in 2025.
- The last three Income towards Parent Company figures came in at $504510.0 (Q4 2025), -$181953.0 (Q3 2025), and -$323340.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504,510.00 |
| Sep 30, 2025 | -181,953.00 |
| Jun 30, 2025 | -323,340.00 |
| Mar 31, 2025 | -948,105.00 |
| Dec 31, 2024 | -439,555.00 |
| Sep 30, 2024 | -685,719.00 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | -4.10 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.07 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -9.43 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.93 Mn |
| Jun 30, 2021 | -9.80 Mn |
| Mar 31, 2021 | -7.69 Mn |